SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Machaon who wrote (17970)3/26/1998 11:40:00 PM
From: Henry Niman  Respond to of 32384
 
It's hard to say what additional cancers could be targets. Panretin of course has been shown to be effective against APL, which is also a smaller market. In animals, Panretin prevents breast cancer and synergizes with Tamoxifen to prevent breast cancer (the above cases are for the oral form). I'm not sure about other topical applications.